Literature DB >> 2175588

Antigens of infectious laryngotracheitis herpesvirus defined by monoclonal antibodies.

J J York1, S Sonza, M R Brandon, K J Fahey.   

Abstract

Monoclonal antibodies to glycoprotein and protein antigens of infectious laryngotracheitis virus (ILTV) were divided into five groups on the basis of their reactivity in immunofluorescence and Western blotting. Group I antibodies recognised a single band of 60 K and Group II antibodies recognised bands of 205, 160, 115, 90 and 85 k in Western blotting. In immunofluorescence both these groups of antibodies reacted with antigens located in the cytoplasm of fixed virus-infected cells and they also reacted with unfixed cells, suggesting that these antigens are on the surface of virus-infected cells. While Group I monoclonal antibodies did not react with extracts of tunicamycin-treated cells, some Group II antibodies recognised bands of decreased molecular weight compared to those present in untreated cells. The reactivity of the Group II antibodies with extracts of tunicamycin-treated cells suggested that they recognised at least three different epitopes which was confirmed by ELISA additivity assays. Monoclonal antibodies of Group III, Group IV and Group V recognised several low molecular weight proteins from 45 to 24 k. Immunofluorescence studies showed that these were nuclear and cytoplasmic antigens that were not present on the surface of virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175588     DOI: 10.1007/BF01310527

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  32 in total

1.  Synthesis and processing of bovine herpesvirus 1 glycoproteins.

Authors:  S van Drunen Littel-van den Hurk; L A Babiuk
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Analysis of three late varicella-zoster virus proteins, a 125,000-molecular-weight protein and gp1 and gp3.

Authors:  A Vafai; Z Wroblewska; M Wellish; M Green; D Gilden
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

4.  Requirements for transport of HSV-1 glycoproteins to the cell surface membrane of human fibroblasts and Vero cells.

Authors:  B Norrild; I Virtanen; B Pedersen; L Pereira
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

5.  Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice.

Authors:  K J Cremer; M Mackett; C Wohlenberg; A L Notkins; B Moss
Journal:  Science       Date:  1985-05-10       Impact factor: 47.728

6.  Varicella-zoster virus p32/p36 complex is present in both the viral capsid and the nuclear matrix of the infected cell.

Authors:  W E Friedrichs; C Grose
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

7.  Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B.

Authors:  M R McDermott; F L Graham; T Hanke; D C Johnson
Journal:  Virology       Date:  1989-03       Impact factor: 3.616

8.  Laryngotracheitis (Gallid-1) herpesvirus infection in the chicken. 4. Latency establishment by wild and vaccine strains of ILT virus.

Authors:  T J Bagust
Journal:  Avian Pathol       Date:  1986       Impact factor: 3.378

9.  Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.

Authors:  E M Cantin; R Eberle; J L Baldick; B Moss; D E Willey; A L Notkins; H Openshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

10.  A structural investigation of the Epstein-Barr (EB) virus membrane antigen glycoprotein, gp340.

Authors:  A J Morgan; A R Smith; R N Barker; M A Epstein
Journal:  J Gen Virol       Date:  1984-02       Impact factor: 3.891

View more
  3 in total

1.  A genomic map of infectious laryngotracheitis virus and the sequence and organization of genes present in the unique short and flanking regions.

Authors:  M A Wild; S Cook; M Cochran
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

2.  Humoral and cell-mediated immune responses to the glycoproteins of infectious laryngotracheitis herpesvirus.

Authors:  J J York; K J Fahey
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Use of lambda gt11 and monoclonal antibodies to map the gene for the 60,000 dalton glycoprotein of infectious laryngotracheitis virus.

Authors:  K Kongsuwan; M A Johnson; C T Prideaux; M Sheppard
Journal:  Virus Genes       Date:  1993-09       Impact factor: 2.332

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.